Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
- 5 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 96 (6) , 1155-1164
Abstract
Th1 and Th17 cells have been considered as effectors in mouse EAE and in the human counterpart, MS. Recently, IL-22, a Th17-related, proinflammatory cytokine, has been associated with a new Th cell subset, defined as Th22, involved in chronic inflammatory conditions, such as psoriasis; the role of IL-22 in MS has not yet been elucidated. Here, we report that similar to Th17 cells, the number of Th22 cells increased in the PB and the CSF of RR MS patients, especially during the active phases of the disease. However, as opposed to Th17 cells, the expansion of Th22 cells occurred before the active phases of the disease. Th22 cells were found to be specific for the autoantigen MBP and also expressed high levels of CCR6 and T-bet, as for Th17 cells, indicating that Th22 self-reactive cells could have CNS-homing properties and be pathogenic in active RRMS patients. Conversely to Th17 cells, Th22 cells displayed lower levels of IFNAR1 and were insensitive to IFN-β inhibition. These data suggest that expansion of Th22 cells in MS could be one of the factors that critically influence resistance to IFN-β therapy.Keywords
Funding Information
- Federazione Italiana Sclerosi Multipla (2009/R19, 2011/R/28)
- Associazione Italiana per la Ricerca sul Cancro (11643, 5×1000, 12182)
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Progetti di Rilevante Interesse Nazionale
- Ministero della Salute, Progetto Integrato Oncologia
- Regione Piemonte: Ricerca Industriale e Sviluppo Precompetitivo
- Ricerca Industriale “Converging Technologies”
- Progetti strategici su tematiche di interesse regionale o sovra regionale
- Ricerca Sanitaria Finalizzata
- Ricerca Sanitaria Applicata
This publication has 37 references indexed in Scilit:
- The many faces of Th17 cellsCurrent Opinion in Immunology, 2011
- TH17 cytokines in autoimmune neuro-inflammationCurrent Opinion in Immunology, 2011
- IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitisGenes & Immunity, 2010
- Circulating Th17, Th22, and Th1 Cells Are Increased in PsoriasisJournal of Investigative Dermatology, 2010
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitisNature Medicine, 2010
- T-bet is essential for encephalitogenicity of both Th1 and Th17 cellsJournal of Experimental Medicine, 2009
- Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursorJournal of Experimental Medicine, 2008
- The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in miceJournal of Clinical Investigation, 2008
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Rating neurologic impairment in multiple sclerosisNeurology, 1983